Ribonucleoprotein Transfection for CRISPR/Cas9-Mediated Gene Knockout in Primary T Cells. Curr Protoc

immunol2019,124(1)e69)

Engineering of CRISPR-Cas 12b for human genome editing. ( Nature, 2019, 10(1): 212)

CRISPR-Cas9 genome engineering of primary CD4+ T cells for the interrogation of Hiv-host factor interactions ( Nat

Protocols,2019,14(1)1-27)

Bacteria-free minicircle DNA system to generate integration-free CAR-T cells (J Med Genetics, 2019, 56: 10-17)

Guide Swap enables genome-scale pooled CRISPR-Cas9 screening in human primary cells (Nat Methods, 2018, 15(11))

Nucleofection with Plasmid DNA for CRISPR/Cas9-Mediated Inactivation of Programmed Cell Death Protein 1 in CD133-

pecifIc CAR T Cells (Hum Gene Ther, 2018)

Optimized RNP transfection for highly efficient CRISPRICas9-mediated gene knockout in primary T cells. J Exp